“Acute hepatitis E”的搜索结果，显示 351-360 项，共有 9873 项

1. 内分泌科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the effects of improving glycemic control, and/or reducing glycemic variability on gastric emptying, ...

2. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol.

3. 蜂窝织炎- 医生与科室- 妙佑医疗国际

   E; 未找到姓氏以该字母开头的医生F F; 未找到姓氏以该 ... Acute kidney inury, Anemia, Hypoglycemia, High ... hepatitis, Myocardial ischemia, Endocarditis, Nephritis, ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

6. 急性肝衰竭- 医生与科室- 妙佑医疗国际

   来自妙佑医疗国际的新闻. image Mayo Clinic collaborates on ARPA-H award to develop a bioprinted liver for acute liver failure · image (VIDEO) Why more liver ...

7. 外科 - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical ...

8. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   The purpose of this study is to identify and evaluate a vocal signal capable of distinguishing active IBD flares from remission in patients with ulcerative ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

10. 血液科- 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...